Medpharm targeting increased growth through PE investment

By Staff Reporter

- Last updated on GMT

GettyImages/pichet_w
GettyImages/pichet_w
Ampersand Capital Partners has invested in drug delivery technology firm MedPharm.

Healthcare private equity (PE) investment firm Ampersand Capital Partners has made a multi-million dollar investment in contract topical and transdermal product manufacturer MedPharm.

While the exact figure has not been disclosed, a spokesperson from MedPharm told us the investment will be used to further grow its business.

Up to now MedPharm has been self-funded and grown organically​,” we were told. “Whilst we have had double digit annual growth for the last three years and expanded successfully in the US, we now need access to additional capital to strategically exploit the major opportunities we see in our chosen markets.”

MedPharm’s services include formulation development, performance testing, clinical supply manufacture and drug administration technologies, including transdermal and ocular delivery platforms.

Ampersand, meanwhile, is invested in a number of pharma and healthcare service firms, including fellow contract manufacturing organisations (CMOs) Brammer Bio, LakePharma, and Avista Pharma.

But while MedPharm said it is aware that Ampersand invests in several complimentary areas, we were told: “There are no immediate plans to leverage these as we concentrate on MedPharm’s existing strategic plan.”

Related news

Related products

show more

From Candidate to Clinic- European Capabilities

From Candidate to Clinic- European Capabilities

Catalent Pharma Solutions | 22-Oct-2018 | Technical / White Paper

Catalent’s Nottingham, UK facility focuses on early stage development of small molecule drug candidates from the bench to clinic. This facility offers...

Fill Release at the Right Time in the Right Place

Fill Release at the Right Time in the Right Place

Gelita AG | 19-Sep-2018 | Technical / White Paper

From rapid release in the stomach for e.g. analgesics to enteric release for fills with unpleasant aftertaste – GELITA delivers the respective gelatine...

Strategies to Select and Deliver the Right Candidate

Strategies to Select and Deliver the Right Candidate

Catalent Pharma Solutions | 05-Mar-2018 | Technical / White Paper

Does your candidate have what it takes to succeed? Do you have the information needed to make the right decisions about your candidate’s path to the clinic?...

Related suppliers

Follow us

Products

View more